Basic Science of Pediatric Brain Tumors

[1]  Roland Eils,et al.  Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma , 2013, Nature Genetics.

[2]  David T. W. Jones,et al.  Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study. , 2013, The Lancet. Oncology.

[3]  Liliana Goumnerova,et al.  Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1 , 2013, Proceedings of the National Academy of Sciences.

[4]  Heather L. Mulder,et al.  Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas , 2013, Nature Genetics.

[5]  David T. W. Jones,et al.  Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. , 2012, Cancer cell.

[6]  Hideo Nakamura,et al.  Markers of survival and metastatic potential in childhood CNS primitive neuro-ectodermal brain tumours: an integrative genomic analysis. , 2012, The Lancet. Oncology.

[7]  Kristian Cibulskis,et al.  A remarkably simple genome underlies highly malignant pediatric rhabdoid cancers. , 2012, The Journal of clinical investigation.

[8]  Matthew J. Betts,et al.  Dissecting the genomic complexity underlying medulloblastoma , 2012, Nature.

[9]  P. Febbo,et al.  An animal model of MYC-driven medulloblastoma. , 2012, Cancer cell.

[10]  Charmaine D. Wilson,et al.  A prognostic gene expression signature in infratentorial ependymoma , 2012, Acta Neuropathologica.

[11]  David T. W. Jones,et al.  Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma , 2012, Nature.

[12]  Li Ding,et al.  Somatic Histone H3 Alterations in Paediatric Diffuse Intrinsic Pontine Gliomas and Non-Brainstem Glioblastomas , 2012, Nature Genetics.

[13]  Scott L. Pomeroy,et al.  Molecular subgroups of medulloblastoma: the current consensus , 2011, Acta Neuropathologica.

[14]  Barbara S. Paugh,et al.  Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  W. Yung,et al.  An integrated in vitro and in vivo high-throughput screen identifies treatment leads for ependymoma. , 2011, Cancer cell.

[16]  Gary D Bader,et al.  Delineation of two clinically and molecularly distinct subgroups of posterior fossa ependymoma. , 2011, Cancer cell.

[17]  C. Roberts,et al.  SWI/SNF nucleosome remodellers and cancer , 2011, Nature Reviews Cancer.

[18]  David T. W. Jones,et al.  An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. , 2011, The Journal of clinical investigation.

[19]  Kirsten Schmieder,et al.  Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.

[20]  Pablo Tamayo,et al.  Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway , 2010, Nature Medicine.

[21]  Yiai Tong,et al.  Subtypes of medulloblastoma have distinct developmental origins , 2010, Nature.

[22]  Scott L Pomeroy,et al.  Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. , 2010, Cancer cell.

[23]  Richard G Grundy,et al.  Integrated molecular genetic profiling of pediatric high-grade gliomas reveals key differences with the adult disease. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  Amar Gajjar,et al.  Cross-species genomics matches driver mutations and cell compartments to model ependymoma , 2010, Nature.

[25]  N. Alon,et al.  TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[26]  V. P. Collins,et al.  Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors. , 2009, Cancer cell.

[27]  Michael D. Taylor,et al.  The genetic and epigenetic basis of ependymoma , 2009, Child's Nervous System.

[28]  John T. Powers,et al.  Lin28 Enhances Tumorigenesis and is Associated With Advanced Human Malignancies , 2009, Nature Genetics.

[29]  David T. W. Jones,et al.  Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. , 2008, Cancer research.

[30]  Robert Machold,et al.  Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. , 2008, Cancer cell.

[31]  A. Hoischen,et al.  Frequent loss of chromosome 9, homozygous CDKN2A/p14ARF/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomas , 2007, Oncogene.

[32]  G. Reifenberger,et al.  Molecular genetic analysis of central nervous system germ cell tumors with comparative genomic hybridization , 2006, Modern Pathology.

[33]  J. Rutka,et al.  Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  N. Shams,et al.  Genetics of choroid plexus tumors. , 2006, Neurosurgical focus.

[35]  Amar Gajjar,et al.  Radial glia cells are candidate stem cells of ependymoma. , 2005, Cancer cell.

[36]  S. Hirohashi,et al.  Short Communication Craniopharyngiomas of Adamantinomatous Type Harbor -Catenin Gene Mutations , 2002 .

[37]  J. Kros,et al.  Desmoplastic infantile astrocytoma and ganglioglioma: a search for genomic characteristics , 2002, Acta Neuropathologica.

[38]  O. Wiestler,et al.  Chromosomal imbalances in choroid plexus tumors. , 2002, The American journal of pathology.

[39]  D. Brat,et al.  Pediatric Neuroblastic Brain Tumors Containing Abundant Neuropil and True Rosettes , 2000, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[40]  Steven J. M. Jones,et al.  Subgroup-specific structural variation across 1,000 medulloblastoma genomes , 2012, Nature.